Package 16110-916-30

Brand: tazorac

Generic: tazarotene
NDC Package

Package Facts

Identity

Package NDC 16110-916-30
Digits Only 1611091630
Product NDC 16110-916
Product ID 16110-916_ee97b76e-eb11-4165-ae85-1277eba9ff35
Description

1 TUBE in 1 CARTON (16110-916-30) / 30 g in 1 TUBE

Marketing

Marketing Status
Marketed Since 2020-02-03
Brand tazorac
Generic tazarotene
Sample Package No

Linked Drug Pages (1)

TAZORAC ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["CUTANEOUS"], "spl_id": "ee97b76e-eb11-4165-ae85-1277eba9ff35", "openfda": {"nui": ["N0000175607", "M0018962"], "upc": ["0316110915609", "0316110916606", "0316110915302", "0316110916309"], "unii": ["81BDR9Y8PS"], "spl_set_id": ["021744d1-a6d7-4ad6-99c2-7187c24e64c6"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (16110-916-30)  / 30 g in 1 TUBE", "package_ndc": "16110-916-30", "marketing_start_date": "20200203"}, {"sample": false, "description": "1 TUBE in 1 CARTON (16110-916-60)  / 60 g in 1 TUBE", "package_ndc": "16110-916-60", "marketing_start_date": "20200203"}], "brand_name": "TAZORAC", "product_id": "16110-916_ee97b76e-eb11-4165-ae85-1277eba9ff35", "dosage_form": "CREAM", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "16110-916", "generic_name": "tazarotene", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZORAC", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".1 mg/g"}], "application_number": "NDA021184", "marketing_category": "NDA", "marketing_start_date": "20200203", "listing_expiration_date": "20261231"}